Applied Therapeutics Inc (APLT)
4.76
-0.05
(-1.04%)
USD |
NASDAQ |
May 07, 12:54
Applied Therapeutics 1 Year Total Returns (Daily): 204.4% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | 204.4% |
| May 03, 2024 | 185.0% |
| May 02, 2024 | 179.6% |
| May 01, 2024 | 146.7% |
| April 30, 2024 | 160.0% |
| April 29, 2024 | 153.5% |
| April 26, 2024 | 181.6% |
| April 25, 2024 | 214.8% |
| April 24, 2024 | 291.8% |
| April 23, 2024 | 371.5% |
| April 22, 2024 | 366.2% |
| April 19, 2024 | 352.0% |
| April 18, 2024 | 428.1% |
| April 17, 2024 | 468.2% |
| April 16, 2024 | 516.0% |
| April 15, 2024 | 505.3% |
| April 12, 2024 | 500.0% |
| April 11, 2024 | 595.8% |
| April 10, 2024 | 606.0% |
| April 09, 2024 | 587.2% |
| April 08, 2024 | 598.3% |
| April 05, 2024 | 622.5% |
| April 04, 2024 | 632.3% |
| April 03, 2024 | 679.2% |
| April 02, 2024 | 685.4% |
| Date | Value |
|---|---|
| April 01, 2024 | 680.4% |
| March 28, 2024 | 729.3% |
| March 27, 2024 | 710.7% |
| March 26, 2024 | 694.0% |
| March 25, 2024 | 703.5% |
| March 22, 2024 | 658.4% |
| March 21, 2024 | 625.8% |
| March 20, 2024 | 671.2% |
| March 19, 2024 | 557.4% |
| March 18, 2024 | 525.9% |
| March 15, 2024 | 576.4% |
| March 14, 2024 | 553.9% |
| March 13, 2024 | 571.4% |
| March 12, 2024 | 568.4% |
| March 11, 2024 | 605.1% |
| March 08, 2024 | 607.3% |
| March 07, 2024 | 568.7% |
| March 06, 2024 | 573.0% |
| March 05, 2024 | 536.1% |
| March 04, 2024 | 611.3% |
| March 01, 2024 | 620.7% |
| February 29, 2024 | 605.0% |
| February 28, 2024 | 632.7% |
| February 27, 2024 | 463.6% |
| February 26, 2024 | 424.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.96%
Minimum
Jun 23 2022
729.3%
Maximum
Mar 28 2024
37.79%
Average
-33.10%
Median
Mar 24 2021
1 Year Total Returns (Daily) Benchmarks
| Sarepta Therapeutics Inc | 3.08% |
| Fate Therapeutics Inc | -25.70% |
| Viking Therapeutics Inc | 242.1% |
| Terns Pharmaceuticals Inc | -53.49% |
| Edgewise Therapeutics Inc | 109.6% |